Adaptimmune Therapeutics
ADAP
#10251
Rank
S$18.85 M
Marketcap
S$0.07113
Share price
0.00%
Change (1 day)
-91.58%
Change (1 year)

Adaptimmune Therapeutics (ADAP) Fails to deliver data

Key failure to deliver metrics for Adaptimmune Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Adaptimmune Therapeutics (ADAP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Adaptimmune Therapeutics (ADAP) - since 2015

Volume in USD (price x number of shares), data since 2015

Adaptimmune Therapeutics (ADAP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$8.25 M1325.75%
2024S$0.57 M-86.57%
2023S$4.31 M424.88%
2022S$0.82 M-74.5%
2021S$3.22 M-92.83%
2020S$44.92 M883.34%
2019S$4.56 M-18.66%
2018S$5.61 M202.64%
2017S$1.85 M182.01%
2016S$0.65 M-91.71%
2015S$7.93 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novavax
NVAX
S$15.95 MS$65.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
S$0 MS$0.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
S$25.29 MS$36.91 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Exelixis
EXEL
S$1.77 MS$15.33 M๐Ÿ‡บ๐Ÿ‡ธ USA